Synthesising enablers and barriers to hepatocellular carcinoma surveillance-A systematic review of qualitative findings.
Moussa D, Flores JE, Doyle JS, Ryan M, Wallace J, Howell J
Availability of point-of-care HBV tests in resource-limited settings.
Lau DTY, Jackson K, Picchio CA, Kramvis A, Sonderup M, Lemoine M, Matthews G, Howell J, Coffin CS, Hellard M, Lee AU, Anderson DA, Kerth HA, Lee EE, Tavis JE, Dandri M, Revill PA, Spearman CW, Penicaud C, Levrero M, El-Sayed M, ICE-HBV POC Model in Resource Limited Settings working group
Hepatitis B
Overcoming disparities in hepatocellular carcinoma outcomes in First Nations Australians: a strategic plan for action.
Howell J, Combo T, Binks P, Bragg K, Bukulatjpi S, Campbell K, Clark PJ, Carroll M, Davies J, de Santis T, Muller KR, Nguyen B, Olynyk JK, Shackel N, Valery PC, Wigg AJ, George J, Roberts SK
Alcohol and Other Drugs Hepatitis B Hepatitis C
Improving Hepatocellular Carcinoma Surveillance Outcomes in Patients with Cirrhosis after Hepatitis C Cure: A Modelling Study.
Cumming J, Scott N, Howell J, Flores JE, Pavlyshyn D, Hellard ME, Winata LS, Ryan M, Sutherland T, Thompson AJ, Doyle JS, Sacks-Davis R
Hepatitis C
Same-visit hepatitis C testing and treatment to accelerate cure among people who inject drugs (the QuickStart Study): a cluster randomised cross-over trial protocol.
Doyle JS, Heath K, Elsum I, Douglass C, Wade A, Kasza J, Allardice K, Von Bibra S, Chan K, Camesella B, Guzman R, Bryant M, Thompson AJ, Stoové MA, Snelling TL, Scott N, Spelman T, Anderson D, Richmond J, Howell J, Andric N, Dietze PM, Higgs P, Sacks-Davis R, Forbes AB, Hellard ME, Pedrana AE
Hepatitis C